IMPROVE MEDICAL INIMPROVE MEDICAL INIMPROVE MEDICAL IN

IMPROVE MEDICAL IN

No trades
See on Supercharts
Market capitalization
‪1.98 B‬CNY
−0.35CNY
‪−63.20 M‬CNY
‪636.10 M‬CNY
‪280.04 M‬
Beta (1Y)
0.80
Employees (FY)
936
Change (1Y)
−133 −12.44%
Revenue / Employee (1Y)
‪95.72 K‬CNY
Net income / Employee (1Y)
‪−9.51 K‬CNY

About IMPROVE MEDICAL IN


CEO
Guan Hua Deng
Headquarters
Zhuhai
Founded
1996
ISIN
CNE100000JL3
FIGI
BBG000PXN094
Improve Medical Instruments Co., Ltd. engages in the provision of clinical care and testing laboratory. Its products include vacuum blood collection systems, lancets, needle holder, microbiological and disposable swabs, vacuum blood off capping machine, peripheral blood collection tube, automatic blood analyzer and urine specimen collection system. The company was founded on August 19, 1996 and is headquartered in Zhuhai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 300030 is 6.84 CNY — it has decreased by −4.75% in the past 24 hours. Watch IMPROVE MEDICAL IN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange IMPROVE MEDICAL IN stocks are traded under the ticker 300030.
300030 stock has fallen by −5.18% compared to the previous week, the month change is a −9.97% fall, over the last year IMPROVE MEDICAL IN has showed a −20.47% decrease.
300030 reached its all-time high on Jun 15, 2015 with the price of 38.00 CNY, and its all-time low was 3.31 CNY and was reached on Jul 10, 2024. View more price dynamics on 300030 chart.
See other stocks reaching their highest and lowest prices.
300030 stock is 13.55% volatile and has beta coefficient of 0.80. Track IMPROVE MEDICAL IN stock price on the chart and check out the list of the most volatile stocks — is IMPROVE MEDICAL IN there?
Today IMPROVE MEDICAL IN has the market capitalization of ‪1.98 B‬, it has increased by 4.50% over the last week.
Yes, you can track IMPROVE MEDICAL IN financials in yearly and quarterly reports right on TradingView.
300030 net income for the last quarter is ‪−37.24 M‬ CNY, while the quarter before that showed ‪−2.08 M‬ CNY of net income which accounts for ‪−1.69 K‬% change. Track more IMPROVE MEDICAL IN financial stats to get the full picture.
As of Nov 25, 2024, the company has 936.00 employees. See our rating of the largest employees — is IMPROVE MEDICAL IN on this list?
Like other stocks, 300030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMPROVE MEDICAL IN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMPROVE MEDICAL IN technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMPROVE MEDICAL IN stock shows the buy signal. See more of IMPROVE MEDICAL IN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.